Filing Details
- Accession Number:
- 0000791908-16-000163
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-11 17:26:05
- Reporting Period:
- 2016-10-07
- Filing Date:
- 2016-10-11
- Accepted Time:
- 2016-10-11 17:26:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 791908 | Xoma Corp | XOMA | Pharmaceutical Preparations (2834) | 942756657 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1600865 | R James Neal | C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710 | Vp Business Development | No | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2016-10-07 | 2,500 | $0.45 | 413,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 13,192 | Indirect | by 401(k) |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016.
- The sale price is an average price. Transactions were executed in multiple trades ranging at prices from $0.4413 to $0.4550.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
- Includes unvested RSUs reported on Table I.
Billionaire Hedge Funds
